VAMP-Associated Protein B (VAPB) Promotes Breast Tumor Growth by Modulation of Akt Activity

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Rao, Meghana ^a   Song, Wenqiang ^a   Jiang, Aixiang ^a,b   Shyr, Yu ^a,b   Lev, Sima ^d   Greenstein, David ^e   Brantley Sieders, Dana ^a   Chen, Jin ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN KINASE B; UNCLASSIFIED DRUG; VESICLE ASSOCIATED MEMBRANE PROTEIN ASSOCIATED PROTEIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; TISSUE MICROARRAY; TUMOR SPHEROID;

ANALYSIS OF VARIANCE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICROARRAY ANALYSIS; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PLASMIDS; SPHEROIDS, CELLULAR; SURVIVAL ANALYSIS; VESICULAR TRANSPORT PROTEINS;

MOUSE MAMMARY TUMOR VIRUS;

EID: 84867017573     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046281     Document Type: Article

References (45)

1. Nishimura Y, Hayashi M, Inada H, Tanaka T, (1999) Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochem Biophys Res Commun 254: 21-26.
2. Weir ML, Klip A, Trimble WS, (1998) Identification of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed protein that binds to VAMP. Biochem J 333 (Pt 2): 247-251.
3. Moumen A, Virard I, Raoul C, (2011) Accumulation of wildtype and ALS-linked mutated VAPB impairs activity of the proteasome. PLoS One 6: e26066.
4. Skehel PA, Fabian-Fine R, Kandel ER, (2000) Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc Natl Acad Sci U S A 97: 1101-1106.
5. Soussan L, Burakov D, Daniels MP, Toister-Achituv M, Porat A, et al. (1999) ERG30, a VAP-33-related protein, functions in protein transport mediated by COPI vesicles. J Cell Biol 146: 301-311.
6. Gkogkas C, Middleton S, Kremer AM, Wardrope C, Hannah M, et al. (2008) VAPB interacts with and modulates the activity of ATF6. Hum Mol Genet 17: 1517-1526.
7. Skehel PA, Martin KC, Kandel ER, Bartsch D, (1995) A VAMP-binding protein from Aplysia required for neurotransmitter release. Science 269: 1580-1583.
8. Loewen CJ, Roy A, Levine TP, (2003) A conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAP. EMBO J 22: 2025-2035.
9. Tsuda H, Han SM, Yang Y, Tong C, Lin YQ, et al. (2008) The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell 133: 963-977.
10. Kanekura K, Nishimoto I, Aiso S, Matsuoka M, (2006) Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J Biol Chem 281: 30223-30233.
11. Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa A, Middleton S, et al. (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75: 822-831.
12. Suzuki H, Kanekura K, Levine TP, Kohno K, Olkkonen VM, et al. (2009) ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J Neurochem 108: 973-985.
13. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
14. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527.
15. Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, et al. (2008) The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Invest 118: 64-78.
16. Chen J, (2012) Regulation of tumor initiation and metastatic progression by eph receptor tyrosine kinases. Adv Cancer Res 114: 1-20.
17. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
18. Lindsley CW, Zhao Z, Leister WH, Robinson RG, Barnett SF, et al. (2005) Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg Med Chem Lett 15: 761-764.
19. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AAM, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. New England Journal of Medicine 347: 1999-2009.
20. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
21. Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, et al. (2002) Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 21: 7011-7026.
22. Amarilio R, Ramachandran S, Sabanay H, Lev S, (2005) Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J Biol Chem 280: 5934-5944.
23. Muraoka RS, Koh Y, Roebuck LR, Sanders ME, Brantley-Sieders D, et al. (2003) Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1. Mol Cell Biol 23: 8691-8703.
24. Debnath J, Muthuswamy SK, Brugge JS, (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268.
25. Ueda Y, Wang S, Dumont N, Yi JY, Koh Y, et al. (2004) Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility. J Biol Chem 279: 24505-24513.
26. Brantley DM, Chen CL, Muraoka RS, Bushdid PB, Bradberry JL, et al. (2001) Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell 12: 1445-1455.
27. Arriola E, Marchio C, Tan DS, Drury SC, Lambros MB, et al. (2008) Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines. Lab Invest 88: 491-503.
28. Rizki A, Weaver VM, Lee SY, Rozenberg GI, Chin K, et al. (2008) A human breast cell model of preinvasive to invasive transition. Cancer Res 68: 1378-1387.
29. Edgren H, Murumagi A, Kangaspeska S, Nicorici D, Hongisto V, et al. (2011) Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biol 12: R6.
30. Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, et al. (2008) An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 68: 6084-6091.
31. Peretti D, Dahan N, Shimoni E, Hirschberg K, Lev S, (2008) Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. Mol Biol Cell 19: 3871-3884.
32. D'Souza-Schorey C, Chavrier P, (2006) ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 7: 347-358.
33. Gillingham AK, Munro S, (2007) The small G proteins of the Arf family and their regulators. Annu Rev Cell Dev Biol 23: 579-611.
34. Spang A, (2002) ARF1 regulatory factors and COPI vesicle formation. Curr Opin Cell Biol 14: 423-427.
35. Plutner H, Cox AD, Pind S, Khosravi-Far R, Bourne JR, et al. (1991) Rab1b regulates vesicular transport between the endoplasmic reticulum and successive Golgi compartments. J Cell Biol 115: 31-43.
36. Stenmark H, (2009) Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10: 513-525.
37. Boulay PL, Cotton M, Melancon P, Claing A, (2008) ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells. J Biol Chem 283: 36425-36434.
38. Kagiwada S, Zen R, (2003) Role of the yeast VAP homolog, Scs2p, in INO1 expression and phospholipid metabolism. J Biochem 133: 515-522.
39. Jansen M, Ohsaki Y, Rita Rega L, Bittman R, Olkkonen VM, et al. (2011) Role of ORPs in sterol transport from plasma membrane to ER and lipid droplets in mammalian cells. Traffic 12: 218-231.
40. Kawano M, Kumagai K, Nishijima M, Hanada K, (2006) Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT. J Biol Chem 281: 30279-30288.
41. Loewen CJ, Levine TP, (2005) A highly conserved binding site in vesicle-associated membrane protein-associated protein (VAP) for the FFAT motif of lipid-binding proteins. J Biol Chem 280: 14097-14104.
42. Lapierre LA, Tuma PL, Navarre J, Goldenring JR, Anderson JM, (1999) VAP-33 localizes to both an intracellular vesicle population and with occludin at the tight junction. Journal of Cell Science 112: 3723-3732.
43. Miller MA, Ruest PJ, Kosinski M, Hanks SK, Greenstein D, (2003) An Eph receptor sperm-sensing control mechanism for oocyte meiotic maturation in Caenorhabditis elegans. Genes Dev 17: 187-200.
44. Chen J, Zhuang G, Frieden L, Debinski W, (2008) Eph receptors and Ephrins in cancer: common themes and controversies. Cancer Res 68: 10031-10033.
45. Vaught D, Brantley-Sieders DM, Chen J, (2008) Eph receptors in breast cancer: roles in tumor promotion and tumor suppression. Breast Cancer Res 10: 217.